Pasternak Andy 4
4 · Context Therapeutics Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Pasternak Andy
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-13+20,685→ 20,685 totalExercise: $1.03Exp: 2035-01-12→ Common Stock (20,685 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.